SCHEMBL10270573

SCHEMBL10270573

CC(C)[C@H]1CC[C@@H](C(=O)NCC(C)(C)O)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ROCK2 O75116 3/20 0.43
ROCK1 Q13464 3/20 0.43
LMNA P02545 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KMT2A Q03164 2/20 0.37
PSMB5 P28074 1/20 0.36
HCRTR2 O43614 1/20 0.35
NAMPT P43490 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
POLB P06746 2/20 0.34
HTT P42858 2/20 0.34
ACACB O00763 1/20 0.34
MTNR1A P48039 3/20 0.33
MTNR1B P49286 3/20 0.33
RPS6KA5 O75582 2/20 0.33
PKN2 Q16513 2/20 0.33
LRRK2 Q5S007 2/20 0.33
CHUK O15111 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17132555 1.00 HSD17B10 (0.50) HSD17B10SMN1; SMN2ROCK2ROCK1LMNA
SCHEMBL16477306 0.83 HSD17B10 (0.46) HSD17B10SMN1; SMN2ROCK2ROCK1LMNA
SCHEMBL10270138 0.83 HSD17B10 (0.46) HSD17B10SMN1; SMN2ROCK2ROCK1LMNA
SCHEMBL14654910 0.81 SMN1; SMN2 (0.55) HSD17B10SMN1; SMN2KMT2ANAMPTPOLB
SCHEMBL17133510 0.81 SMN1; SMN2 (0.55) HSD17B10SMN1; SMN2KMT2ANAMPTPOLB
SCHEMBL15200319 0.81 SMN1; SMN2 (0.55) HSD17B10SMN1; SMN2KMT2ANAMPTPOLB
SCHEMBL17132547 0.79 LMNA (0.49) HSD17B10SMN1; SMN2ROCK2ROCK1LMNA
SCHEMBL24474315 0.77 ROCK2 (0.46) HSD17B10SMN1; SMN2ROCK2ROCK1LMNA
SCHEMBL10270129 0.77 ROCK2 (0.46) HSD17B10ROCK2ROCK1LMNATDP1
SCHEMBL24474359 0.77 ROCK2 (0.46) HSD17B10ROCK2ROCK1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018668-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE AMGEN INC. (US) 2012-02-09 WO disclosed